Sarcopenia, and its association with cardiometabolic and functional characteristics in Taiwan: Results from I-Lan Longitudinal Aging Study

Geriatrics and Gerontology International

Volumn 14, Issue SUPPL.1, 2014, Pages 36-45

  Liu, Li Kuo ^a,b   Lee, Wei Ju ^a,b   Chen, Liang Yu ^a,b   Hwang, An Chun ^a,b   Lin, Ming Hsien ^a,b   Peng, Li Ning ^a,b   Chen, Liang Kung ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Cardiovascular disease; Community dwelling elderly; Frailty; Sarcopenia

Indexed keywords

ADULT; AGED; AGING; ARTERIAL WALL THICKNESS; ARTICLE; BODY COMPOSITION; BODY MASS; BONE DENSITY; CARDIOMETABOLIC RISK; CHARLSON COMORBIDITY INDEX; COGNITION; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOGRAPHY; FEMALE; GRIP STRENGTH; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MENTAL FUNCTION; METABOLIC PARAMETERS; MIDDLE AGED; MUSCLE STRENGTH; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; PHYSICAL PERFORMANCE; PREVALENCE; PRIORITY JOURNAL; SARCOPENIA; SKELETAL MUSCLE; SMOKING; TAIWAN; WAIST CIRCUMFERENCE; WALKING SPEED;

CARDIOVASCULAR DISEASE; COMMUNITY-DWELLING ELDERLY; FRAILTY; SARCOPENIA;

AGED; AGING; BODY COMPOSITION; CAROTID INTIMA-MEDIA THICKNESS; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; HEMODYNAMICS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MOTOR ACTIVITY; MUSCLE STRENGTH; MUSCLE, SKELETAL; SARCOPENIA; TAIWAN;

EID: 84892891836     PISSN: 14441586     EISSN: 14470594     Source Type: Journal    
DOI: 10.1111/ggi.12208     Document Type: Article

References (56)

1. Cruz-Jentoft AJ, Landi F, Topinkova E, Michel JP. Understanding sarcopenia as a geriatric syndrome. Curr Opin Clin Nutr Metab Care 2010; 13: 1-7.
2. Kavita Karnik DJM. Review of tools and technologies to assess multi-system functional impairment and frailty. Clin Med Geriatr 2009; 3: 1-8.
3. Cruz-Jentoft AJ, Baeyens JP, Bauer JM etal. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010; 39: 412-423.
4. Goodpaster BH, Park SW, Harris TB etal. The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci 2006; 61: 1059-1064.
5. Karakelides H, Nair KS. Sarcopenia of aging and its metabolic impact. Curr Top Dev Biol 2005; 68: 123-148.
6. Park SW, Goodpaster BH, Lee JS etal. Excessive loss of skeletal muscle mass in older adults with type 2 diabetes. Diabetes Care 2009; 32: 1993-1997.
7. Cesari M, Pedone C, Chiurco D etal. Physical performance, sarcopenia and respiratory function in older patients with chronic obstructive pulmonary disease. Age Ageing 2012; 41: 237-241.
8. Zamboni M, Rossi A, Corzato F, Bambace C, Mazzali G, Fantin F. Sarcopenia, Cachexia and Congestive Heart Failure in the Elderly. Endocr Metab Immune Disord Drug Targets 2013; 13: 58-67.
9. von Haehling S, Steinbeck L, Doehner W, Springer J, Anker SD. Muscle wasting in heart failure: an overview. Int J Biochem Cell Biol 2013; 45: 2257-2265.
10. Lee JS, Auyeung TW, Kwok T, Lau EM, Leung PC, Woo J. Associated factors and health impact of sarcopenia in older chinese men and women: a cross-sectional study. Gerontology 2007; 53: 404-410.
11. Ochi M, Kohara K, Tabara Y etal. Arterial stiffness is associated with low thigh muscle mass in middle-aged to elderly men. Atherosclerosis 2010; 212: 327-332.
12. Cesari M, Pahor M, Lauretani F etal. Skeletal muscle and mortality results from the InCHIANTI Study. J Gerontol A Biol Sci Med Sci 2009; 64: 377-384.
13. Metter EJ, Talbot LA, Schrager M, Conwit R. Skeletal muscle strength as a predictor of all-cause mortality in healthy men. J Gerontol A Biol Sci Med Sci 2002; 57: B359-B365.
14. Cosqueric G, Sebag A, Ducolombier C, Thomas C, Piette F, Weill-Engerer S. Sarcopenia is predictive of nosocomial infection in care of the elderly. Br J Nutr 2006; 96: 895-901.
15. Landi F, Cruz-Jentoft AJ, Liperoti R etal. Sarcopenia and mortality risk in frail older persons aged 80 years and older: results from ilSIRENTE study. Age Ageing 2013; 42: 203-209.
16. Abellan van Kan G. Epidemiology and consequences of sarcopenia. J Nutr Health Aging 2009; 13: 708-712.
17. Tichet J, Vol S, Goxe D, Salle A, Berrut G, Ritz P. Prevalence of sarcopenia in the French senior population. J Nutr Health Aging 2008; 12: 202-206.
18. Chen LK, Inoue H, Won CW etal. Challenges of urban aging in Taiwan: summary of urban aging forum. J Clin Gerontol Geriatr 2013; 4: 97-101.
19. Chen CY. Meeting the challenges of eldercare in Taiwan's aging society. J Clin Gerontol Geriatr 2010; 1: 2-4.
20. Lin CC, Li CI, Meng NH etal. Frailty and its associated factors in an elderly taiwanese metropolitan population. J Am Geriatr Soc 2013; 61: 292-294.
21. Lee WJ, Liu LK, Peng LN, Lin MH, Chen LK. Comparisons of sarcopenia defined by IWGS and EWGSOP criteria among older people: results from the I-Lan longitudinal aging study. J Am Med Dir Assoc 2013; 14: 528 e1-528 e7.
22. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383.
23. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
24. Hebert R, Carrier R, Bilodeau A. The Functional Autonomy Measurement System (SMAF): description and validation of an instrument for the measurement of handicaps. Age Ageing 1988; 17: 293-302.
25. Radloff LS. The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977; 1: 385-401.
26. Guigoz Y. The Mini Nutritional Assessment (MNA) review of the literature-What does it tell us? J Nutr Health Aging 2006; 10: 466-485; discussion 85-7.
27. Xue QL, Bandeen-Roche K, Varadhan R, Zhou J, Fried LP. Initial manifestations of frailty criteria and the development of frailty phenotype in the Women's Health and Aging Study II. J Gerontol A Biol Sci Med Sci 2008; 63: 984-990.
28. Witham MD, Sumukadas D, McMurdo ME. ACE inhibitors for sarcopenia-as good as exercise training? Age Ageing 2008; 37: 363-365.
29. Rolfson DB, Majumdar SR, Tsuyuki RT, Tahir A, Rockwood K. Validity and reliability of the Edmonton Frail Scale. Age Ageing 2006; 35: 526-529.
30. Woods JL, Iuliano-Burns S, King SJ, Strauss BJ, Walker KZ. Poor physical function in elderly women in low-level aged care is related to muscle strength rather than to measures of sarcopenia. Clin Interv Aging 2011; 6: 67-76.
31. Liu LK, Lee WJ, Liu CL etal. Age-related skeletal muscle mass loss and physical performance in Taiwan: implications to diagnostic strategy of sarcopenia in Asia. Geriatr Gerontol Int 2013; 13: 964-971.
32. Baumgartner RN, Koehler KM, Gallagher D etal. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 1998; 147: 755-763.
33. Newman AB, Kupelian V, Visser M etal. Sarcopenia: alternative definitions and associations with lower extremity function. J Am Geriatr Soc 2003; 51: 1602-1609.
34. Kanters SD, Algra A, van Leeuwen MS, Banga JD. Reproducibility of in vivo carotid intima-media thickness measurements: a review. Stroke 1997; 28: 665-671.
35. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999; 84 (10): 3666-3672.
36. Janssen I, Heymsfield SB, Low RR. relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 2002; 50: 889-896.
37. Lim S, Kwon SY, Yoon JW etal. Association between body composition and pulmonary function in elderly people: the Korean Longitudinal Study on Health and Aging. Obesity (Silver Spring) 2011; 19: 631-638.
38. Pongchaiyakul C, Limpawattana P, Kotruchin P, Rajatanavin R. Prevalence of sarcopenia and associated factors among Thai population. J Bone Miner Metab 2013; 31: 346-350.
39. Delmonico MJ, Harris TB, Lee JS etal. Alternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and women. J Am Geriatr Soc 2007; 55: 769-774.
40. Kim YS, Lee Y, Chung YS etal. Prevalence of sarcopenia and sarcopenic obesity in the Korean population based on the Fourth Korean National Health and Nutritional Examination Surveys. J Gerontol A Biol Sci Med Sci 2012; 67: 1107-1113.
41. Bijlsma AY, Meskers CG, Ling CH etal. Defining sarcopenia: the impact of different diagnostic criteria on the prevalence of sarcopenia in a large middle aged cohort. Age (Dordr) 2013; 35: 871-881.
42. Figueiredo CP, Domiciano DS, Lopes JB etal. Prevalence of sarcopenia and associated risk factors by two diagnostic criteria in community-dwelling older men: the São Paulo Ageing & Health Study (SPAH). Osteoporos Int 2013; doi: 10.1007/s00198-013-2455-x.
43. Mathus-Vliegen EM. Obesity and the elderly. J Clin Gastroenterol 2012; 46: 533-544.
44. Kim JK, Choi SR, Choi MJ etal. Prevalence of and factors associated with sarcopenia in elderly patients with end-stage renal disease. Clin Nutr 2013; pii: S0261-5614(13)00102-7. doi:10.1016/j.clnu.2013.04.002
45. Bottiggi KHA. The association between change in motor function and cognition in older adults: a descriptive review. Phys Ther Rev 2008; 13: 91-101.
46. Bahat G, Saka B, Tufan F etal. Prevalence of sarcopenia and its association with functional and nutritional status among male residents in a nursing home in Turkey. Aging Male 2010; 13: 211-214.
47. Stephen WC, Janssen I. Sarcopenic-obesity and cardiovascular disease risk in the elderly. J Nutr Health Aging 2009; 13: 460-466.
48. Chung JY, Kang HT, Lee DC, Lee HR, Lee YJ. Body composition and its association with cardiometabolic risk factors in the elderly: a focus on sarcopenic obesity. Arch Gerontol Geriatr 2013; 56: 270-278.
49. Verschueren S, Gielen E, O'Neill TW etal. Sarcopenia and its relationship with bone mineral density in middle-aged and elderly European men. Osteoporos Int 2013; 24: 87-98.
50. Capozza RF, Cointry GR, Cure-Ramirez P, Ferretti JL, Cure-Cure C. A DXA study of muscle-bone relationships in the whole body and limbs of 2512 normal men and pre- and post-menopausal women. Bone 2004; 35: 283-295.
51. Peters SA, Lind L, Palmer MK etal. Increased age, high body mass index and low HDL-C levels are related to an echolucent carotid intima-media: the METEOR study. J Intern Med 2012; 272: 257-266.
52. Kato A, Ishida J, Endo Y etal. Association of abdominal visceral adiposity and thigh sarcopenia with changes of arteriosclerosis in haemodialysis patients. Nephrol Dial Transplant 2011; 26: 1967-1976.
53. Pahkala K, Heinonen OJ, Simell O etal. Association of physical activity with vascular endothelial function and intima-media thickness. Circulation 2011; 124: 1956-1963.
54. Abe T, Thiebaud RS, Loenneke JP, Bemben MG, Loftin M, Fukunaga T. Influence of severe sarcopenia on cardiovascular risk factors in nonobese men. Metab Syndr Relat Disord 2012; 10: 407-412.
55. Sanada K, Iemitsu M, Murakami H etal. Adverse effects of coexistence of sarcopenia and metabolic syndrome in Japanese women. Eur J Clin Nutr 2012; 66: 1093-1098.
56. Lee JS, Auyeung TW, Leung J, Kwok T, Leung PC, Woo J. Physical frailty in older adults is associated with metabolic and atherosclerotic risk factors and cognitive impairment independent of muscle mass. J Nutr Health Aging 2011; 15: 857-862.